Sort
82,697 grants matching “vaccine development”
Bacteria and Host in TB Transmission
$1,697,099David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Novel approaches for vaccine design
$1,696,945Michel C Nussenzweig · Rockefeller University · P01 · FY2013 · AI
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,696,890Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,696,890Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
SBIR Phase II: Machine Learning for Rapid Automated Viral Infectivity Assays (COVID-19)
$1,696,774Christian Lang · Viqi Llc · · FY2022 · TIP
University of Rochester Center for AIDS Research
$1,696,203Stephen Dewhurst · University Of Rochester · P30 · FY2015 · AI
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis and Other Viral Diseases
$1,696,123T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
US-UK Collaboration: Integrating ecology, epidemiology, and human interests to guide strategic management of zoonoses in complex wildlife reservoirs
$1,695,154Mostafa Zamanian · University Of Wisconsin-Madison · · FY2020 · BIO
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
$1,695,141Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · AI
Bacteria and Host in TB Transmission
$1,695,066David Alland · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
Influenza Vaccine Development
$1,695,001Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Influenza Vaccine Development
$1,695,001Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Influenza Vaccine Development
$1,695,001Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Adjuvant Enhanced Antiviral Immunity
$1,694,391Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2009 · AI
Toward a Universal Influenza Virus Vaccine
$1,694,246Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · AI
Toward a Universal Influenza Virus Vaccine
$1,694,246Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · AI
The Pathogenesis, Diagnosis, And Treatment of Systemic Mast Cell Disorders
$1,694,050Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Military HIV Research Program (MHRP) Clinical Trial Unit
$1,693,914Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2025 · AI
IMPACTA PERU CLINICAL TRIALS UNIT
$1,693,877Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2018 · AI
AIDS CLINICAL TRIALS UNIT
$1,693,188Stanford University · U01 · FY2002 · AI
Administrative Core
$1,692,994Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2021 · AI
Novel Approaches to Stem Cell Transplantation
$1,692,811Nelson J. Chao · Duke University · P01 · FY2006 · CA
University of Rochester HIV/AIDS Clinical Trials Unit
$1,692,796Michael C Keefer · University Of Rochester · UM1 · FY2014 · AI
Mechanisms of naturally-acquired immunity to malaria
$1,692,688Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Miami Womens Interagency HIV Study WIHS
$1,692,089Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2014 · AI